Elaine K. Sorg - 28 Feb 2023 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
SVP, US COMMERCIAL OPERATIONS
Signature
Steven L. Scrogham, attorney-in-fact for Elaine K. Sorg
Issuer symbol
ABBV
Transactions as of
28 Feb 2023
Net transactions value
-$5,387,923
Form type
4
Filing time
02 Mar 2023, 16:07:04 UTC
Previous filing
21 Feb 2023
Next filing
05 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Tax liability $3,062,458 -19,850 -32% $154.28 42,829 28 Feb 2023 Direct
transaction ABBV Common Stock, $0.01 par value Options Exercise $1,402,780 +15,003 +35% $93.50 57,832 01 Mar 2023 Direct
transaction ABBV Common Stock, $0.01 par value Sale $2,325,465 -15,003 -26% $155.00 42,829 01 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Option (Right to Buy) Options Exercise $1,402,780 -15,003 -100% $93.50 0 01 Mar 2023 Common Stock 15,003 $93.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).